Shilpa Medicare Limited

NSE SHILPAMED.NS

Shilpa Medicare Limited Shareholders' Equity for the year ending March 31, 2024: USD 216.84 M

Shilpa Medicare Limited Shareholders' Equity is USD 216.84 M for the year ending March 31, 2024, a -0.06% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Shilpa Medicare Limited Shareholders' Equity for the year ending March 31, 2023 was USD 216.97 M, a -9.59% change year over year.
  • Shilpa Medicare Limited Shareholders' Equity for the year ending March 31, 2022 was USD 239.98 M, a 18.84% change year over year.
  • Shilpa Medicare Limited Shareholders' Equity for the year ending March 31, 2021 was USD 201.94 M, a 14.48% change year over year.
  • Shilpa Medicare Limited Shareholders' Equity for the year ending March 31, 2020 was USD 176.41 M, a 2.36% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
Loading...
SV Wall Street
NSE: SHILPAMED.NS

Shilpa Medicare Limited

CEO Mr. Vishnukanth Chaturbhuj Bhutada B. Pharm
IPO Date Dec. 3, 2009
Location India
Headquarters Shilpa House
Employees 1,007
Sector Healthcare
Industries
Description

Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (API's), intermediates, and formulations in India, the United States, Europe, and internationally. It offers oncology and non-oncology API's.; and new drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company also provides contract manufacturing of various dosage forms, such as tablets, capsules, liquid injections, lyophilized injectables, and sterile dry powder injectables. It is also involved in the wind power generation activities. Shilpa Medicare Limited was incorporated in 1987 and is headquartered in Raichur, India.

StockViz Staff

February 2, 2025

Any question? Send us an email